| Literature DB >> 35444423 |
Juan Mundisugih1,2, Caroline X Gao1,3, Jillian F Ikin1, Michael J Abramson1, David Brown1, Sinjini Biswas1,2, Elizabeth M Dewar2,4, Danny Liew1, Dion Stub1,2,4.
Abstract
Background and Aims: Mega-wild fires are exposing large communities to weeks or months of high concentration smoke-related fine particulate air pollution (PM). However, little research has examined the long-term vascular responses from exposure to PM of this concentration and duration. We investigated whether level of exposure to 6 weeks of PM from the 2014 Hazelwood coal mine fire was associated with abnormal vascular responses approximately four years later.Entities:
Keywords: air pollution; epidemiology; flow mediated dilatation; particulate matter; time to peak diameter; vascular responses
Mesh:
Substances:
Year: 2022 PMID: 35444423 PMCID: PMC9013675 DOI: 10.2147/VHRM.S339439
Source DB: PubMed Journal: Vasc Health Risk Manag ISSN: 1176-6344
Demographic and Clinical Profile of the Study Sample (N=387) Across Exposure Levels
| Characteristic | Exposure Level | ||||
|---|---|---|---|---|---|
| Unexposed N=162 | Low Exposure N=78 | Medium Exposure N=73 | High Exposure N=74 | ||
| 0.09 (0.50) | 6.25 (1.80) | 11.2 (1.60) | 28.6 (11.1) | ||
| 5.52 (27.5) | 87.5 (22.5) | 143 (52.3) | 421 (230) | ||
| 0.25 (0.10) | 0.28 (0.20) | 0.25 (0.10) | 0.26 (0.20) | 0.37 | |
| 55–64 years | 35 (30%) | 13 (19%) | 15 (24%) | 15 (25%) | 0.64 |
| 65–74 years | 75 (37%) | 41 (50%) | 31 (40%) | 35 (41%) | |
| 75+ years | 52 (33%) | 24 (31%) | 27 (36%) | 24 (34%) | |
| 92 (57%) | 49 (62%) | 41 (54%) | 42 (57%) | 0.78 | |
| 157 (99%) | 76 (99%) | 69 (95%) | 74 (100%) | ||
| Employed | 41 (29%) | 12 (17%) | 8 (14%) | 12 (19%) | 0.19 |
| Retired | 111 (66%) | 59 (73%) | 58 (78%) | 56 (72%) | |
| Other | 8 (5%) | 7 (10%) | 7 (9%) | 6 (9%) | |
| Secondary up to year 10 | 55 (33%) | 32 (40%) | 31 (41%) | 26 (36%) | 0.44 |
| Secondary year 11–12 | 33 (21%) | 12 (15%) | 14 (20%) | 10 (14%) | |
| Certificate (trade/ apprenticeship/technicians) | 55 (35%) | 27 (36%) | 23 (32%) | 24 (30%) | |
| University or other Tertiary degree | 18 (11%) | 7 (9%) | 5 (8%) | 14 (20%) | |
| Underweight/Normal (BMI<25kg/m2) | 40 (24%) | 10 (16%) | 14 (19%) | 12 (18%) | 0.34 |
| Overweight (25≤BMI<30kg/m2) | 57 (37%) | 21 (28%) | 29 (41%) | 26 (37%) | |
| Obese (BMI≥30kg/m2) | 65 (39%) | 47 (56%) | 30 (41%) | 36 (45%) | |
| Non-smoker | 86 (54%) | 31 (39%) | 37 (51%) | 30 (42%) | |
| Ex-smoker | 68 (41%) | 35 (44%) | 33 (45%) | 36 (46%) | |
| Current smoker | 8 (4%) | 12 (16%) | 3 (4%) | 8 (12%) | |
| Non-drinker | 37 (23%) | 24 (30%) | 16 (20%) | 20 (27%) | 0.21 |
| Low risk | 50 (31%) | 20 (24%) | 33 (45%) | 27 (35%) | |
| High risk | 74 (46%) | 34 (47%) | 24 (35%) | 27 (38%) | |
| 63 (40%) | 36 (43%) | 41 (58%) | 47 (62%) | ||
| 79 (48%) | 47 (60%) | 39 (49%) | 34 (46%) | 0.33 | |
| Cardiovascular disease | 80 (45%) | 35 (37%) | 35 (41%) | 38 (45%) | 0.67 |
| Diabetes | 34 (19%) | 26 (29%) | 17 (23%) | 23 (29%) | 0.25 |
| Hypertension | 126 (77%) | 66 (82%) | 62 (84%) | 63 (84%) | 0.45 |
| High cholesterol | 22 (15%) | 7 (9%) | 11 (17%) | 4 (4%) | 0.08 |
| Blood pressure lowering medications | 99 (60%) | 58 (70%) | 50 (67%) | 54 (72%) | 0.28 |
| Diabetes medications | 18 (11%) | 12 (13%) | 14 (20%) | 16 (19%) | 0.28 |
| Anti-inflammatory | 12 (7%) | 11 (15%) | 3 (4%) | 7 (9%) | 0.15 |
| Aspirin | 12 (6%) | 8 (9%) | 14 (18%) | 15 (17%) | |
| Lipid modifying agents | 63 (37%) | 40 (49%) | 33 (43%) | 49 (65%) | |
| 37 (21%) | 18 (24%) | 17 (24%) | 19 (26%) | 0.86 | |
Notes: p values in bold are smaller than 0.05.
Abbreviations: PM2.5, fine particulate matter with an aerodynamic diameter <2.5µm; SD, standard deviation; BMI, body mass index.
Crude Comparison of Study Outcomes Between Unexposed, Low, Medium and High Exposure Levels
| Outcome variables | Exposure Level | ||||
|---|---|---|---|---|---|
| Unexposed N=162 | Low Exposure N=78 | Medium Exposure N=73 | High Exposure N=74 | ||
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | ||
| 0.48 (0.10) | 0.48 (0.10) | 0.47 (0.10) | 0.46 (0.10) | 0.56 | |
| 0.49 (0.10) | 0.50 (0.10) | 0.49 (0.10) | 0.48 (0.10) | 0.50 | |
| 0.018 (0.001) | 0.019 (0.001) | 0.018 (0.001) | 0.018 (0.001) | 0.86 | |
| 3.98 (2.70) | 4.02 (2.50) | 4.06 (2.50) | 4.09 (2.70) | 0.99 | |
| 3.19 (4.80) | 3.54 (3.60) | 3.75 (5.90) | 2.78 (2.90) | 0.46 | |
| Peak within 30s | 57 (36%) | 11 (13%) | 15 (22%) | 17 (23%) | |
| Peak between 30 and 60s | 67 (43%) | 33 (44%) | 26 (36%) | 22 (34%) | |
| Peak between 60 and 90s | 17 (10%) | 18 (25%) | 18 (26%) | 22 (31%) | |
| Peak after 90s | 6 (4%) | 8 (12%) | 7 (10%) | 5 (5%) | |
| No response within 180s | 12 (7%) | 6 (7%) | 6 (7%) | 6 (7%) | |
| 21 (15%) | 14 (21%) | 15 (29%) | 8 (12%) | 0.11 | |
Notes: p values in bold are smaller than 0.05.
Abbreviations: FMD, flow mediated dilatation; ECG, electrocardiogram.
Figure 1Comparison of FMD (%) distribution (A) between Morwell and Sale, and (B) between exposure levels.
Figure 2Comparison of time to peak diameter distribution (A) between Morwell and Sale and (B) between exposure groups.
Potential Predictive Factors for Flow Mediated Dilatation and Time to Peak Diameter
| Predictors | Flow Mediated Dilatation (%)a | Time to Peak Diameterb | ||
|---|---|---|---|---|
| Coef (95% CI) | OR (95% CI) | |||
| 0.04 (−0.19, 0.26) | 0.76 | 0.94 (0.77, 1.13) | 0.49 | |
| −0.11 (−0.74, 0.51) | 0.72 | 2.71 (1.56, 4.69) | ||
| −0.05 (−0.46, 0.36) | 0.81 | 1.13 (0.81, 1.59) | 0.47 | |
| 2.12 (1.12, 3.12) | 0.82 (0.40, 1.66) | 0.57 | ||
| −0.05 (−0.58, 0.48) | 0.85 | 1.53 (1.03, 2.26) | ||
| −0.89 (−1.56, −0.22) | 0.83 (0.50, 1.38) | 0.47 | ||
| 0.05 (−0.01, 0.10) | 0.09 | 1.00 (0.95, 1.04) | 0.91 | |
| Non-drinker | Ref | Ref | ||
| Low risk (AUDIT-C score: Females 1–2, Males 1–3) | −0.41 (−1.14, 0.32) | 0.27 | 0.88 (0.50, 1.55) | 0.66 |
| High risk (AUDIT-C score: Females ≥ 3, Males ≥ 4) | −0.30 (−1.05, 0.45) | 0.43 | 1.08 (0.64, 1.85) | 0.77 |
| Non-smoker | Ref | Ref | ||
| Ex-smoker | −0.92 (−1.44, −0.40) | 0.71 (0.46, 1.09) | 0.11 | |
| Current smoker | 0.15 (−1.04, 1.34) | 0.80 | 2.55 (1.39, 4.66) | |
| −1.52 (−3.71, 0.67) | 0.17 | 0.35 (0.06, 2.05) | 0.25 | |
| 0.34 (−0.23, 0.92) | 0.24 | 1.19 (0.76, 1.86) | 0.44 | |
| −17.05 (−21.9, −12.2) | 1.41 (0.03, 57.35) | 0.86 | ||
| −0.24 (−0.72, 0.24) | 0.33 | 1.02 (0.65, 1.59) | 0.94 | |
| −0.32 (−0.84, 0.20) | 0.22 | 0.87 (0.58, 1.30) | 0.49 | |
| −0.07 (−0.79, 0.65) | 0.84 | 0.72 (0.39, 1.34) | 0.30 | |
| −0.33 (−0.84, 0.17) | 0.20 | 1.18 (0.79, 1.77) | 0.43 | |
| −0.15 (−0.68, 0.37) | 0.56 | 0.77 (0.49, 1.21) | 0.26 | |
| −0.04 (−0.89, 0.81) | 0.93 | 0.89 (0.51, 1.53) | 0.67 | |
Notes: p values in bold are smaller than 0.05. aMultivariable linear regression model (weighted and imputed) was used to evaluate associations between predictors and FMD% controlling for all listed confounding factors. b Ordinal logistic regression model (weighted and imputed) was used to evaluate associations between predictors and time to peak FMD, controlling for all listed confounding factors.
Abbreviations: PM2.5, fine particulate matter with an aerodynamic diameter <2.5µm; SD, standard deviation; BMI, body mass index.